Page last updated: 2024-11-06

4-hydroxyquinoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Hydroxyquinoline is a heterocyclic organic compound with the formula C9H7NO. It is a white solid that is soluble in organic solvents. 4-Hydroxyquinoline is an important building block in organic synthesis and is used in the preparation of pharmaceuticals, dyes, and other fine chemicals. It has been shown to have a variety of biological activities, including antifungal, antibacterial, and anti-inflammatory effects. The compound is also a known inhibitor of certain enzymes, including tyrosine kinases and DNA topoisomerases. 4-Hydroxyquinoline is a valuable synthetic intermediate and has been widely studied for its potential medicinal applications. Research efforts have focused on understanding its biological activities, exploring its use in drug discovery, and developing new synthetic methods for its preparation.'
```

4-quinolone : A quinolone that is 1,4-dihydroquinoline substituted by an oxo group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID69141
CHEMBL ID1232567
CHEBI ID15815
CHEBI ID155900
SCHEMBL ID10031
MeSH IDM0105117

Synonyms (75)

Synonym
KUC100207
brn 1524969
einecs 210-268-2
4-oxo-1,4-dihydroquinoline
4-oxoquinoline
4-quinolone
CHEMBL1232567
nsc-3183
nsc3183
4-quinolinol ,
kynurine
4-chinolinol
CHEBI:15815 ,
ccris 4329
4-quinolinol (8ci,9ci)
nsc263800
529-37-3
nsc-263800
OPREA1_521432
KUC100207N
quinolin-4(1h)-one
inchi=1/c9h7no/c11-9-5-6-10-8-4-2-1-3-7(8)9/h1-6h,(h,10,11
4(1h)-quinolinone
EU-0033653
C06343
4-hydroxyquinoline ,
611-36-9
quinolin-4-ol ,
4-quinolinol, 98%
quinoline, 4-hydroxy-
nsc 3183
bdbm14321
AC-516
AKOS000277429
1h-quinolin-4-one
Q0029
STL129466
A8493
AKOS005738113
EN300-54449
m1o131wxfo ,
unii-m1o131wxfo
FT-0618750
AM20061372
hydroxyquinoline, 4-
AB4075
AM81187
SCHEMBL10031
3KPU
mfcd00006777
SY002846
1h-quinoline-4one
4(1h)-quinolone
4-hydroxy-quinoline
4-hydroxy quinoline
W-105189
J-650306
DTXSID50209980
STL445698
J-512661
mfcd00956391
CS-D1012
Z818727120
FT-0712331
4,5-dichloro-3-thiophenecarboxylicacid
F0266-1090
Q27098240
AS-10846
BCP27058
SY105850
SB67475
CHEBI:155900
1,4-dihydroquinolin-4-one
PB43148
HY-59208
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
monohydroxyquinolineA hydroxyquinoline carrying a single hydroxy substituent.
quinolone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (16)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cationic trypsinBos taurus (cattle)Ki2,000.00000.00001.07539.0000AID1797191
Tryptase beta-2Homo sapiens (human)Ki2,000.00000.00101.05323.7000AID1797191
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
Chain A, Phenylethanolamine N-methyltransferaseHomo sapiens (human)Kd690.00004.6000234.7667690.0000AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
proteolysisCationic trypsinBos taurus (cattle)
digestionCationic trypsinBos taurus (cattle)
proteolysisTryptase beta-2Homo sapiens (human)
regulation of autophagyHistone acetyltransferase KAT8Homo sapiens (human)
negative regulation of epithelial to mesenchymal transitionHistone acetyltransferase KAT8Homo sapiens (human)
neurogenesisHistone acetyltransferase KAT8Homo sapiens (human)
myeloid cell differentiationHistone acetyltransferase KAT8Homo sapiens (human)
negative regulation of type I interferon productionHistone acetyltransferase KAT8Homo sapiens (human)
post-embryonic hemopoiesisHistone acetyltransferase KAT8Homo sapiens (human)
transcription initiation-coupled chromatin remodelingHistone acetyltransferase KAT8Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone acetyltransferase KAT8Homo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase KAT8Homo sapiens (human)
oogenesisHistone acetyltransferase KAT8Homo sapiens (human)
regulation of mRNA processingHistone acetyltransferase KAT8Homo sapiens (human)
positive regulation of transcription initiation by RNA polymerase IIHistone acetyltransferase KAT8Homo sapiens (human)
positive regulation of skeletal muscle satellite cell differentiationHistone acetyltransferase KAT8Homo sapiens (human)
regulation of mitochondrial transcriptionHistone acetyltransferase KAT8Homo sapiens (human)
regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (17)

Processvia Protein(s)Taxonomy
endopeptidase activityCationic trypsinBos taurus (cattle)
serine-type endopeptidase activityCationic trypsinBos taurus (cattle)
protein bindingCationic trypsinBos taurus (cattle)
metal ion bindingCationic trypsinBos taurus (cattle)
serpin family protein bindingCationic trypsinBos taurus (cattle)
serine-type endopeptidase activityTryptase beta-2Homo sapiens (human)
protein bindingTryptase beta-2Homo sapiens (human)
serine-type peptidase activityTryptase beta-2Homo sapiens (human)
histone H4K5 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K8 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K16 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
transcription coactivator activityHistone acetyltransferase KAT8Homo sapiens (human)
protein bindingHistone acetyltransferase KAT8Homo sapiens (human)
histone H4 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
enzyme bindingHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K5 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K8 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
metal ion bindingHistone acetyltransferase KAT8Homo sapiens (human)
histone H4K16 acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingHistone acetyltransferase KAT8Homo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
protein propionyltransferase activityHistone acetyltransferase KAT8Homo sapiens (human)
transcription coregulator activityHistone acetyltransferase KAT8Homo sapiens (human)
chromatin bindingHistone acetyltransferase KAT8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (15)

Processvia Protein(s)Taxonomy
serine protease inhibitor complexCationic trypsinBos taurus (cattle)
collagen-containing extracellular matrixTryptase beta-2Homo sapiens (human)
extracellular spaceTryptase beta-2Homo sapiens (human)
nucleusHistone acetyltransferase KAT8Homo sapiens (human)
chromosomeHistone acetyltransferase KAT8Homo sapiens (human)
kinetochoreHistone acetyltransferase KAT8Homo sapiens (human)
nucleusHistone acetyltransferase KAT8Homo sapiens (human)
nucleoplasmHistone acetyltransferase KAT8Homo sapiens (human)
mitochondrionHistone acetyltransferase KAT8Homo sapiens (human)
nuclear matrixHistone acetyltransferase KAT8Homo sapiens (human)
NSL complexHistone acetyltransferase KAT8Homo sapiens (human)
MSL complexHistone acetyltransferase KAT8Homo sapiens (human)
histone acetyltransferase complexHistone acetyltransferase KAT8Homo sapiens (human)
MLL1 complexHistone acetyltransferase KAT8Homo sapiens (human)
chromatinHistone acetyltransferase KAT8Homo sapiens (human)
NuA4 histone acetyltransferase complexHistone acetyltransferase KAT8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID1797191Enzyme Assay and Determination of the Inhibition Constants from Article 10.1021/bi060173m: \\Structure-guided design of peptide-based tryptase inhibitors.\\2006Biochemistry, May-16, Volume: 45, Issue:19
Structure-guided design of peptide-based tryptase inhibitors.
AID637443Antioxidant activity against toxin solution-induced lipid peroxidation in Sprague-Dawley rat brain homogenates assessed as free MDA levels per mg of tissue at 0.1 by TBARS assay (Rvb = 0.93 +/- 0.09 nmol)2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Antioxidant properties of 4-quinolones and structurally related flavones.
AID683577Inhibition of bocillin FL binding to PBP 5/6 in Escherichia coli MM 294 membrane preparation at 1 mM by gel electrophoresis2012ACS medicinal chemistry letters, Jul-12, Volume: 3, Issue:7
4-quinolones as noncovalent inhibitors of high molecular mass penicillin-binding proteins.
AID1240492Inhibition of equine serum BChE at 10 uM pre-incubated for 5 mins before butyrylthiocholineiodide substrate addition by Ellman's method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Discovery of new acetylcholinesterase inhibitors with small core structures through shape-based virtual screening.
AID637437Antioxidant activity assessed as trolox equivalents ratio of ferric ion reducing activity using fe3+-TPTZ at 0.001 mM by FRAP assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Antioxidant properties of 4-quinolones and structurally related flavones.
AID637438Antioxidant activity assessed as trolox equivalents ratio of ferric ion reducing activity using fe3+-TPTZ at 0.01 mM by FRAP assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Antioxidant properties of 4-quinolones and structurally related flavones.
AID637444Antioxidant activity against toxin solution-induced lipid peroxidation in Sprague-Dawley rat brain homogenates assessed as free MDA levels per mg of tissue at 1 by TBARS assay (Rvb = 0.93 +/- 0.09 nmol)2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Antioxidant properties of 4-quinolones and structurally related flavones.
AID683575Inhibition of bocillin FL binding to PBP 4 in Escherichia coli MM 294 membrane preparation at 1 mM by gel electrophoresis2012ACS medicinal chemistry letters, Jul-12, Volume: 3, Issue:7
4-quinolones as noncovalent inhibitors of high molecular mass penicillin-binding proteins.
AID683573Inhibition of bocillin FL binding to PBP 3 in Escherichia coli MM 294 membrane preparation at 1 mM by gel electrophoresis2012ACS medicinal chemistry letters, Jul-12, Volume: 3, Issue:7
4-quinolones as noncovalent inhibitors of high molecular mass penicillin-binding proteins.
AID637442Antioxidant activity against toxin solution-induced lipid peroxidation in Sprague-Dawley rat brain homogenates assessed as free MDA levels per mg of tissue at 0.01 by TBARS assay (Rvb = 0.93 +/- 0.09 nmol)2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Antioxidant properties of 4-quinolones and structurally related flavones.
AID637439Antioxidant activity assessed as trolox equivalents ratio of ferric ion reducing activity using fe3+-TPTZ at 0.1 mM by FRAP assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Antioxidant properties of 4-quinolones and structurally related flavones.
AID1507713Antioxidant activity assessed as DPPH radical scavenging activity incubated for 15 mins2017European journal of medicinal chemistry, Aug-18, Volume: 136The relevance of K
AID624609Specific activity of expressed human recombinant UGT1A62000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624612Specific activity of expressed human recombinant UGT1A92000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID637441Antioxidant activity against toxin solution-induced lipid peroxidation in Sprague-Dawley rat brain homogenates assessed as free MDA levels per mg of tissue at 0.001 by TBARS assay (Rvb = 0.93 +/- 0.09 nmol)2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Antioxidant properties of 4-quinolones and structurally related flavones.
AID637440Antioxidant activity assessed as ferric ion reducing activity using fe3+-TPTZ at 1 mM by FRAP assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Antioxidant properties of 4-quinolones and structurally related flavones.
AID683571Inhibition of bocillin FL binding to PBP 2 in Escherichia coli MM 294 membrane preparation at 1 mM by gel electrophoresis2012ACS medicinal chemistry letters, Jul-12, Volume: 3, Issue:7
4-quinolones as noncovalent inhibitors of high molecular mass penicillin-binding proteins.
AID1507711Inhibition of KAT3B catalytic domain (1284 to 1673 residues) (unknown origin) using SGRGKGGKGLGKGGAKRHRK-NH2 as substrate after 5 mins in presence of Ac-CoA by fluorescence assay2017European journal of medicinal chemistry, Aug-18, Volume: 136The relevance of K
AID1507731Inhibition of N-terminal His6-tagged KAT8 catalytic domain (125 to 458 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) at 250 uM using SGRGKGGKGLGKGGAKRHRK-NH2 as substrate after 5 mins in presence of Ac-CoA by fluorescence assay2017European journal of medicinal chemistry, Aug-18, Volume: 136The relevance of K
AID1507710Inhibition of KAT2B catalytic domain (492 to 658 residues) (unknown origin) using H-ARTKQTARKSTGGKAPRKQL-OH as substrate after 5 mins in presence of Ac-CoA by fluorescence assay2017European journal of medicinal chemistry, Aug-18, Volume: 136The relevance of K
AID1240491Inhibition of Electrophorus electricus AChE at 10 uM pre-incubated for 5 mins before acetylthiocholine iodide substrate addition by Ellman's method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Discovery of new acetylcholinesterase inhibitors with small core structures through shape-based virtual screening.
AID1507709Inhibition of N-terminal His6-tagged KAT8 catalytic domain (125 to 458 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using SGRGKGGKGLGKGGAKRHRK-NH2 as substrate after 5 mins in presence of Ac-CoA by fluorescence assay2017European journal of medicinal chemistry, Aug-18, Volume: 136The relevance of K
AID637434Antioxidant activity assessed as trolox equivalents ratio of AAPH-induced peroxyl radical scavenging activity at 0.001 mM by ORAC assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Antioxidant properties of 4-quinolones and structurally related flavones.
AID683569Inhibition of bocillin FL binding to PBP 1a/1b in Escherichia coli MM 294 membrane preparation at 1 mM by gel electrophoresis2012ACS medicinal chemistry letters, Jul-12, Volume: 3, Issue:7
4-quinolones as noncovalent inhibitors of high molecular mass penicillin-binding proteins.
AID637436Antioxidant activity assessed as AAPH-induced peroxyl radical scavenging activity at 1 mM by ORAC assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Antioxidant properties of 4-quinolones and structurally related flavones.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2010The Biochemical journal, Oct-01, Volume: 431, Issue:1
Fragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (36.96)18.7374
1990's1 (2.17)18.2507
2000's9 (19.57)29.6817
2010's16 (34.78)24.3611
2020's3 (6.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.03 (24.57)
Research Supply Index3.87 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index40.31 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (97.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]